I migliori Tom Froggatt podcast (2024)

1
Tony de Fougerolles 40:28

3d ago40:28

40:28

Welcome to another episode of CEO Sessions! This week we’re joined by Tony de Fougerolles, a CEO with a fascinating journey through the biotech world. Tony's been at the helm of several companies, sits on multiple boards, and has seen the role of a CEO from many different angles - from securing funding, to building strong company cultures and navig…

1
Marcin Paduch, Metaphore Biotechnologies 48:33

4d ago48:33

48:33

In this week’s episode of Careers in Discovery, we sit down with Marcin Paduch, Head of Platform Biology at Metaphore Biotechnologies. Marcin shares his insight into the exciting work happening at Metaphore, where they’re using the power of biomimicry and machine learning to develop new therapeutics. He explains how their MIMIC platform helps tackl…

1
Emma Banks - ramarketing 49:12

10d ago49:12

49:12

In the very first episode of CEO Sessions, I’m joined by Emma Banks, CEO of ramarketing. We explore the realities of leading a company today, from the challenges of hybrid work to staying true to yourself as a leader. Emma shares her experiences in the pharma industry, the impact of leadership programs like Vistage, and the lessons she’s learned wh…

1
Alistair Henry, UCB 47:57

11d ago47:57

47:57

In this latest episode of Careers in Discovery, we sit down with Alistair Henry, the new Chief Scientific Officer at UCB, to talk about his remarkable 26-year journey with the company. Alistair shares his passion for science and how it led him from a curious teenager to a leader in drug discovery, working on ground-breaking projects in immunology a…

1
Kenny Duncan - Accent Therapeutics 40:22

18d ago40:22

40:22

This week on Careers in Discovery, we're delighted to be joined by Kenny Duncan, SVP of Chemistry at Accent Therapeutics, where we explore the evolving landscape of drug discovery and the critical role chemistry plays in advancing new therapies. Kenny takes us through his incredible career journey, from his early passion for chemistry to becoming a…

1
Richard Law, Exscientia 49:31

25d ago49:31

49:31

Could AI be the key to reducing the high failure rate in drug discovery? This week on Careers in Discovery, we explore this critical question with Richard Law, Chief Business Officer at Exscientia, who has been at the forefront of integrating AI into the Biotech industry for decades. Richard shares his fascinating career journey, from his early day…

1
Hazel Jones, Enhanc3d Genomics 45:20

2M ago45:20

45:20

This week I’m joined by Hazel Jones, CEO of Enhanc3d Genomics. Hazel shares her journey from her early days in Biotech to leading a company at the cutting edge of 3D genomics. We explored Hazel's career path, her transition into a CEO role and her insights on leadership, the significance of networking, and balancing professional and personal life.…

1
Peter Pack 58:55

2M ago58:55

58:55

This week on Careers in Discovery, we are joined by Peter Pack, an influential figure in the biotechnology industry with a career spanning over two decades. Peter's journey has taken him from Germany to the dynamic biotech landscape of the UK, where he now operates as a strategic partner and advisor to private equity firms and startups. In our conv…

1
Jason Mellad, Start Codon 34:58

2M ago34:58

34:58

On this episode, I chat with Jason Mellad, CEO of Start Codon, about the Biotech investment market and startup success. Jason talked about the importance of strong, adaptable teams in early-stage companies and offers plenty of practical advice on understanding the market, recognising weaknesses, and trying to continuously improve. He shared the mos…

1
Jose Munoz-Olaya, Valink Therapeutics 44:52

2M ago44:52

44:52

"Science and technology have always fascinated me, and I've always been one to challenge the status quo." This week on Careers in Discovery, we welcome Jose Munoz-Olaya, Chief Scientific Officer of Valink Therapeutics. Jose shares his journey from an eager intern to a leader in biotechnology, emphasizing the importance of mentorship and the power o…

1
Mike Stubbington, CS Genetics 47:27

2M ago47:27

47:27

Mike Stubbington and CS Genetics are on a mission to democratise single cell genomics. We caught up with Mike recently and discussed what being kind really looks like as a scientist, why you should move on when the time is right, and a whole lot more.Di Tom Froggatt

1
Ben Cross, PhoreMost 46:43

2M ago46:43

46:43

We first interviewed Ben Cross five years ago, when he was the Head of Functional Genomics at Horizon Discovery, and we're delighted to welcome him back to the podcast as CTO of PhoreMost, an innovative target discovery company focused on drugging the undruggable. Ben caught us up on what he's learned over the last five years, including why failing…

1
Shane Hegarty, Axonis Therapeutics 52:51

3M ago52:51

52:51

Shane Hegarty is the Chief Scientific Officer of Axonis Therapeutics, a Boston-based Biotech targeting KCC2 to revive neurons and treat people suffering from neurological disorders. Shane shared with us the story of his transition from academic to Biotech entrepreneur, why communication, persistence, collaboration and focus are critical skills for …

1
Maude Tessier, Seismic Therapeutic 48:31

3M ago48:31

48:31

Maude Tessier is the Chief Business Officer at Seismic Therapeutic, the machine learning immunology company building a discovery platform centred on parallel drug development. Maude joined us on Careers in Discovery to talk about the impact of machine learning on drug development, taking control of her career by literally knocking on doors, balanci…

1
Vern de Biasi, BenevolentAI 48:53

3M ago48:53

48:53

Vern de Biasi is VP of Business Development at BenevolentAI, one of the world's leaders in the application of cutting edge technology to drug discovery. Vern's career has seen him travel the world, from the UK to Italy, China and the US, and he shared with us the key lessons he's learned along the way.…

1
Jordan Lane, Ignota Labs 45:06

3M ago45:06

45:06

Jordan Lane is the Chief Scientific Officer of Ignota Labs, a company leveraging AI to rescue failed drug programmes. Jordan joined us to talk about building conviction, seeking feedback & maintaining networks, the huge opportunity lying in failed research, and why risk is relative in your career.Di Tom Froggatt

1
Preface 11:06

4M ago11:06

11:06

Before we launch into CEO Sessions fully, I wanted to share a little about why I'm doing this podcast and what we're trying to achieve with it. Come along and join the Session, and I'll tell you a bit about my journey as a CEO so far, as well as where I think we're heading.Di Tom Froggatt

1
Pam Garside, Cambridge Angels 41:53

4M ago41:53

41:53

Pam Garside is an experienced angel investor and Chair of Cambridge Angels, one of the UK's leading investor networks. On this epsiode of The Other Side of The Table, we sat down with Pam to discuss the importance of smart money, why tenacity, boldness and perserverance are critical traits for founders, and her top tips on your investment deck. Enj…

1
Bill Eldridge, Isogenica 49:24

5M ago49:24

49:24

Bill Eldridge is an experienced scientific and commercial leader, one of the founding team members of the VHH antibody company Isogenica, and now their CEO. Bill joined us to talk about his career, the huge potential that still exists within antibody discovery and the magic of seeing a 96 well ELISA plate turn blue after months of failure! Enjoy...…

1
Lee Lindley, Mercia Ventures 38:49

6M ago38:49

38:49

We're back on The Other Side of the Table with Lee Lindley, Investment Manager at Mercia Ventures. Lee and I got into a range of topics in this podcast, including the importance of engaging early with investors, thinking beyond your next round and why it's so critical for CEOs to get their team involved in fundraising conversations. Join us for all…

1
Namir Hassan, Zelluna Immunotherapy 46:25

6M ago46:25

46:25

Namir Hassan is the CEO of Zelluna Immunotherapy, a cancer cell therapy company harnessing natural immunity to treat solid tumours. Namir joined us on Careers in Discovery to talk about when precision medicine gets too precise, the importance of servant leadership and trusting the journey in your career. Enjoy!…

1
Hanadi Jabado, Sana Capital 37:33

6M ago37:33

37:33

Hanadi Jabado is the Managing Partner at Sana Capital, a fund with a brilliant mission - to heal the world. Hanadi talked to us on The Other Side of The Table about the investment philosophy behind that mission, why algorithms aren't really what matters, the key role that trust plays in effective founder-investor relationships and why the market ma…

1
Jane Dancer 43:00

6M ago43:00

43:00

Now a Non-Executive at a range of leading Biotech companies including Spirea, PharmEnable, Macomics, NanoSyrinx and Elasmogen, Jane Dancer has built a highly successful career in Business Development in the sector. Jane joined us to discuss that career, how she created a portfolio of NED positions, the real value of an MBA and whether you really ne…

1
Dr Darrin Disley OBE 37:10

7M ago37:10

37:10

Come join me and the ever-insightful Darrin Disley, founding CEO of Horizon Discovery, current Chief Exec of Mogrify and investor in more than 40 Life Sciences and Social Enterprise businesses. In this episode, we got into why angel investors have different motivations, the importance of vision, why getting your cap structure right is absolutely cr…

1
Sean Kendall - ARCH Venture Partners 30:31

7M ago30:31

30:31

I'm back on The Other Side of The Table with Sean Kendall, Partner at ARCH Venture Partners. We're talking his view on the market (including my favourite quote of the series so far - "it's hard to fall out of the basement window"), why everything starts with high quality science, and how to tell if a market is "big enough" for investors.…

1
Mark Wyatt - Northern Gritstone 38:23

7M ago38:23

38:23

This time around I'm with Mark Wyatt, Investment Director at Northern Gritstone, a group focused on realising the potential of innovation from universities across the North of England. In this episode, you'll hear about the importance of purpose to investors, what the due diligence process is really about and why you shouldn't be afraid to show the…

1
Uzma Choudry - Octopus Ventures 30:54

9M ago30:54

30:54

This time around on The Other Side of The Table, come with me to meet Uzma Choudry, Biotech/TechBio investment lead at Octopus Ventures. Uzma built Octopus' TechBio desk and is an active investor and board member at several Biotech and TechBio companies - if you've spent any time on the UK Bio networking scene, you may well have come across her. Th…

1
Gian Seehra 29:18

9M ago29:18

29:18

Next up on The Other Side of The Table, I'm joined by Gian Seehra. Gian founded two successful Biotech companies, raising c. $16m along the way, before heading into the world of VC. During his time at QVentures and Octopus Ventures, he invested into Healthtech and Life Sciences companies, and now runs a business helping Seed to Series B founders se…

1
Jason Foster - Ori Biotech 39:06

9M ago39:06

39:06

On this first episode of The Other Side of the Table, I'm with Jason Foster. Jason is a seasoned entrepreneur, investor and Biotech CEO with an amazing track record on both sides of the funding table, including a very impressive $100m Series B with his current company, Ori Biotech. His insight into the drivers of the current fundraising climate and…

1
Samantha Bailey-Bucktrout, Akamis Bio 51:13

9M ago51:13

51:13

"I see all the other element of my current role - the leadership, management and mentoring - as enabling the science." Samantha Bailey-Bucktrout is the Senior Vice President of Research at Akamis Bio, a company harnessing the power of tumour gene therapy in the fight against cancer. Samantha talked to us about her career in cancer immunotherapy, wh…

1
Beverley Carr, Amphista Therapeutics 43:59

10M ago43:59

43:59

"You can learn corporate finance. You can do Excel modelling. You can read books on negotiation. But I strongly believe that Business Development is an art, and it's something that you can only really learn by doing." Beverley Carr is the Chief Business & Operating Officer of Amphista Therapeutics, a company re-engineering TPD therapies to tackle c…

1
Janette Thomas, Five Alarm Bio 44:54

11M ago44:54

44:54

"I realised that drug development was much more than just research. There's a huge amount of work beyond coming up with a molecule, but research scientists just don't get exposed to it." Janette Thomas has built a career from Researcher to Project Manager, Operations Director and now CEO of Five Alarm Bio, a company focused on novel approaches to a…

1
Dan Williams, SynaptixBio 52:42

11M ago52:42

52:42

"If you've got into science because science itself motivates you, try and stay with it. Do other things too, learn what you need to, but be careful not to leave that science behind." Dan Williams is the CEO of SynaptixBio, a company dedicated to developing lifesaving therapies for severe leukodystrophies. Dan joined us to talk about the challenges …

1
Matthew Duchars, CHAIN Biotech 48:52

12M ago48:52

48:52

"Taking a vaccine from concept and early stage data through to a licensed product that you're putting into millions of people takes 10-15 years on average, but it was done in 10 months. So how did we manage to acheive that? Nobody wanted to be stuck in lockdown forever and so everyone really focused on coming together - a combination of industry, g…

1
Orla Cunningham, Granular Therapeutics & Ultrahuman 8 54:04

12M ago54:04

54:04

"Whatever opportunity arises, it may not be on the path that you think you should be on, but it will bring value. You have to do your best to identify what that value is. So keep an open mind about opportunities - there's sometimes value in applying for something that you only have 30% of the requirements for." Orla Cunningham is the Chief Scientif…

1
Rebecca Godfrey, ExpressionEdits 59:27

1y ago59:27

59:27

"LinkedIn is like the professional Instagram. It looks like people's careers were so easy, mapped out and planned. It doesn't tell of the difficult decisions, the failures, the challenges, the dead ends and having to start again." Rebecca Godfrey is the Chief Operating Officer of ExpressionEdits and the author of "The Leadership Vaccine". Rebecca t…

1
Jenny Barnett, Monument Therapeutics & Five Lives 41:00

1y ago41:00

41:00

"Cancer drugs only started working once we realised that we actually had to measure what was going on in the tumour and match them appropriately [to patients]...we're just on the cusp of that approach being accepted in neuroscience." Jenny Barnett is the CEO of Monument Therapeutics, a Biotech company using precision medicine approaches to develop …

1
Paul Thompson, Mission Therapeutics 49:01

1y ago49:01

49:01

"The most important thing is to enjoy what you're doing. If you're in the lab and enjoying your research, that's great. Keep enjoying it and you'll probably delivery well. If you want to keep focusing on research, you can, and if you want to experience different things, you'll have created the opportunity to do so." Paul Thompson is the Chief Scien…

1
Andy Whiting, Nevrargenics 48:31

1y ago48:31

48:31

"Look at oncology 50 years ago. With huge amounts of investment we now think that most form of cancer are treatable. With investment, understanding, time and research that's possible in neurodegeneration - that you can not just slow or even stop but reverse and repair it." Andy Whiting is the CEO of Nevrargenics, a Biotech company spun out of his r…

1
Ross Breckenridge, Arjuna Therapeutics 56:44

1y ago56:44

56:44

"[As a CEO] you have to force yourself to think about what's happening in your business - and that doesn't mean doing 8 hours of Zoom calls a day. Just as it's the gaps between the notes that make music, it's the gaps between the timetable acitvities that enable strategic thinking." Ross Breckenridge is the CEO of Arjuna Therapeutics, a Biotech com…

1
Jonathan Steckbeck, Peptilogics 47:46

1+ y ago47:46

47:46

"Drug discovery is one of the biggest miracles we can accomplish. You're taking something that didn't exist before, then putting it into the most complex system we know of, hoping that it does one specific thing and not a bunch of other bad things. The fact that it ever works is a miracle." Jonathan Steckbeck is the CEO of Peptilogics, a Biotech co…

1
Steve Trim, Venomtech 1:03:05

1+ y ago1:03:05

1:03:05

"Get experience, talk to people who are doing it, go to networking sessions and interact with business owners - we've all got a story to tell and most are happy to share advice." Steve Trim is the founder and Chief Scientific Officer of Venomtech, a truly unique company that helps Biotech researchers to work with venom-based assays. Steve talked to…

1
Tomas Dias, Mursla 52:56

1+ y ago52:56

52:56

"Embrace being uncomfortable. It's easy to say, I know, but go out there and don't be afraid. It will be challenging, it will make you anxious but if you don't try, [what you want] won't happen." Tomas Dias is the Chief Technology Officer at Mursla, a Biotech company using extracellular vesicles to develop next-generation liquid biopsy tests in ser…

1
Samantha Dale Strasser, Pepper Bio 46:15

1+ y ago46:15

46:15

"As a PhD, you're very focused on the question and the process of how you get things done. Our focus [as a Biotech company] is on what impact we want to have, where we're going and the key questions that our partners are trying to answer." Samantha Dale Strasser is the Chief Scientific Officer of Pepper Bio, the world's first transomic analysis com…

1
Nara Daubeney, Phaim 45:21

1+ y ago45:21

45:21

"It comes down to [the question], 'Why are you here?'. We looked at this project and thought, if we do this and it works, then we have a therapy that could prevent people from progressing down the inevitable slide into insulin dependence, with all the long term impacts that implies. And that would be a really worthwhile course to take." Nara Dauben…

1
Richard Weaver 45:36

1+ y ago45:36

45:36

"Don't think that just because you've done a Biology or Chemistry degree, this is your path forever....I didn't become an entrepreneur until the age of 42. Your [career] path isn't fixed." Richard Weaver is a consultant to Biotech companies on their drug development programmes, specialising in DMPK. Before becoming a consultant, Rich was the founde…

1
Nuno Madeira do Ó, Reflection Therapeutics 43:38

1+ y ago43:38

43:38

"Anybody can be a pair of hands, follow a protocol and do what they're told. If you want more than that, if you want to be a pair of hands with a brain, then you have to think differently." Nuno Madeira do Ó is the CEO of Reflection Therapeutics, a Biotech company harnessing the potential of Tregs to treat inflammatory diseases. Nuno shared the sto…

1
Leigh Brody, AlbionVC 44:08

1+ y ago44:08

44:08

"We are in such an exciting time in Life Sciences...if you have an idea, go for it, because there's a lot of VC money out there...and the appetite to invest early has improved, so it's the right time to speak to investors about potential ideas." Leigh Brody is an entrepreneur, executive and now venture investor at AlbionVC, where she oversees the U…

1
Samuel Woodhouse, CoSyne Therapeutics 51:56

1+ y ago51:56

51:56

"Join a young company. If you're employee number 10, you're 10% of the business as opposed to 1% in a 100 person company. You will learn way more just by osmosis....if you're curious and ask questions." Samuel Woodhouse is the VP of Operations at CoSyne Therapeutics, a technology-driven drug discovery company on a mission to reinvent Pharma from th…

1
Roland Burli, Cerevance 42:10

1+ y ago42:10

42:10

"In the first few years [of your career], what's really important is to establish yourself. You learn a certain skillset in academia...the next thing is to really apply that in the context of a drug discovery project....if you develop a proven track record as a good scientist, good things will happen." Roland Burli is the Vice President of Drug Dis…

Podcast che vale la pena ascoltare

Podcast di Tom Froggatt

Podcast che vale la pena ascoltare

Guida rapida